The use of transgenic animals in the study of diabetic kidney disease

Hormone and Metabolic Research

Volumn 37, Issue SUPPL. 1, 2005, Pages

  Wogensen Bach, Lise ^a   Krag, S ^a   Chai, Q ^a   Ledet, T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Diabetes; Extracellular matrix; Transforming growth factor 1; Transgenic models

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; CONFERENCE PAPER; DIABETIC NEPHROPATHY; DIALYSIS; EXPERIMENTAL DIABETES MELLITUS; EXTRACELLULAR MATRIX; GLOMERULUS BASEMENT MEMBRANE; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY TRANSPLANTATION; KIDNEY TUBULE BASEMENT MEMBRANE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; HUMANS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMALIA;

EID: 20444495721     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-861365     Document Type: Conference Paper

References (97)

1. Borch Johnsen K. The prognosis of insulin-dependent diabetes mellitus. An epidemiological approach. Dan Med Bull 1989; 36: 336-348
2. Andresen JL, Rasmussen LM, Ledet T. Diabetic macroangiopathy and atherosclerosis. Diabetes 1996; 45 Suppl 3: S91-S94
3. Rasmussen LM, Heickendorff L Accumulation of fibronectin in aortas from diabetic patients. A quantitative immunohistochemical and biochemical study. Lab Invest 1989; 61: 440-446
4. Rasmussen LM, Ledet T. Aortic collagen alterations in human diabetes mellitus. Changes in basement membrane collagen content and in the susceptibility of total collagen to cyanogen bromide solubilisation. Diabetologia 1993; 36: 445-453
5. Heickendorff L, Ledet T, Rasmussen LM. Glycosaminoglycans in the human aorta in diabetes mellitus: a study of tunica media from areas with and without atherosclerotic plaque. Diabetologia 1994; 37: 286-292
6. Bunn HF. Nonenzymatic glycosylation of protein: relevance to diabetes. Am J Med 1981; 70: 325-330
7. Flyvbjerg A. The Role of Insulin-like Growth Factor 1 in Initial Renal Hypertrophy in Experimental Diabetes. 1993. Aarhus University. Ref Type: Thesis/Dissertation
8. Suzuki D, Yagame M, Kim Y, Sakai H, Mauer M. Renal in situ hybridization studies of extracellular matrix related molecules in type 1 diabetes mellitus. Nephron 2002; 92: 564-572
9. Abrass CK, Spicer D, Berfield AK, St John PL, Abrahamson DR. Diabetes induces changes in glomerular development and laminin-beta 2 (s-laminin) expression. Am J Pathol 1997; 151: 1131-1140
10. Nerlich A, Schleicher E. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am J Pathol 1991; 139: 889-899
11. Yang CW, Vlassara H, Peten EP, He CJ, Striker GE, Striker LJ. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci U S A 1994; 91: 9436-9440
12. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci U S A 1992; 89: 2873-2877
13. Sinniah R, Khan TN. Renal tubular basement membrane changes in tubulointerstitial damage in patients with glomerular diseases. Ultrastruct Pathol 1999; 23: 359-368
14. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 2000; 15: 290-301
15. Norman JT, Fine LG. Progressive renal disease: fibroblasts, extracellular matrix, and integrins. Exp Nephrol 1999; 7: 167-177
16. Iwano M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens 2004; 13: 279-284
17. Bader R, Bader H, Grund KE, Mackensen-Haen S, Christ H, Bohle A. Structure and function of the kidney in diabetic glomerulosclerosis. Correlations between morphological and functional parameters. Pathol Res Pract 1980; 167: 204-216
18. Schainuck LI, Striker GE, Cutler RE, Benditt EP. Structural-functional correlations in renal disease. II. The correlations. Hum Pathol 1970; 1: 631-641
19. Striker GE, Schainuck LI, Cutler RE, Benditt EP. Structural-functional correlations in renal disease. I. A method for assaying and classifying histopathologic changes in renal disease. Hum Pathol 1970; 1: 615-630
20. Ha TS, Barnes JL, Stewart JL, Ko CW, Miner JH, Abrahamson DR, Sanes JR, Kasinath BS. Regulation of renal laminin in mice with type 11 diabetes. J Am Soc Nephrol 1999; 10: 1931-1939
21. Miner JH. Developmental biology of glomerular basement membrane components. Curr Opin Nephrol Hypertens 1998; 7: 13-19
22. Miner JH. Renal basement membrane components. Kidney Int 1999; 56: 2016-2024
23. Bruijn JA, Roos A, de Geus B, de Heer E. Transforming growth factor-beta and the glomerular extracellular matrix in renal pathology. J Lab Clin Med 1994; 123: 34-47
24. Brees DK, Hutchison FN, Cole GJ, Williams JC Differential effects of diabetes and glomerulonephritis on glomerular basement membrane composition. Proc Soc Exp Biol Med 1996; 212: 69-77
25. Fogo AB. Mesangial matrix modulation and glomerulosclerosis. Exp Nephrol 1999; 7: 147-159
26. Schnaper HW, Kopp JB. Renal fibrosis. Front Biosci 2003; 8: e68-e86
27. Bergijk EC, Van Alderwegen IE, Baelde HJ, de Heer E, Funabiki K, Miyai H, Killen PD, Kalluri RK, Bruijn JA. Differential expression of collagen IV isoforms in experimental glomerulosclerosis. J Pathol 1998; 184: 307-315
28. Muchaneta-Kubara EC, el Nahas AM. Myoflbroblast phenotypes expression in experimental renal scarring. Nephrol Dial Transplant 1997; 12: 904-915
29. Strutz F, Zeisberg M, Ziyadeh FN, Yang CQ, Kalluri R, Muller GA, Neilson EG. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 2002; 61: 1714-1728
30. Okada H, Inoue T, Suzuki H, Strutz F, Neilson EG. Epithelial-mesenchymal transformation of renal tubular epithelial cells in vitro and in vivo. Nephrol Dial Transplant 2000; 15 Suppl 6: 44-46
31. Okada H, Danoff TM, Kalluri R, Neilson EG. Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol 1997; 273: F563-F574
32. Strutz F, Muller GA, Neilson EG. Transdifferentiation: a new angle on renal fibrosis. Exp Nephrol 1996; 4: 267-270
33. Zeisberg M, Bonner G, Maeshima Y, Colorado P, Muller GA, Strutz F, Kalluri R. Renal Fibrosis. Collagen Composition and Assembly Regulates Epithelial-Mesenchymal Transdifferentiation. Am J Pathol 2001; 159: 1313-1321
34. Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial flbrosis. Am J Pathol 2001; 159: 1465-1475
35. Stahl PJ, Felsen D. Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal transdifferentiation: implications for fibrosis in kidney disease. Am J Pathol 2001; 159: 1187-1192
36. Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY. Transforming growth factor-beta regulates tubular epithelial- myofibroblast transdifferentiation in vitro. Kidney Int 1999; 56: 1455-1467
37. Fan JM, Huang XR, Ng YY, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-betal-dependent mechanism in vitro. Am J Kidney Dis 2001; 37: 820-831
38. Rastaldi MP, Ferrario F, Giardino L, Dell'Antonio G, Grillo C, Grillo P, Strutz F, Muller GA, Colasanti G, D'Amico G. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 2002; 62: 137-146
39. Lavaud S, Poirier B, Mandet C, Belair MF, Irinopoulou T, Heudes D, Bazin R, Bariety J, Myara I, Chevalier J. Inflammation is probably not a prerequisite for renal interstitial fibrosis in normoglycemic obese rats. Am J Physiol Renal Physiol 2001; 280: F683-F694
40. Oba S, Kimura K, Suzuki N, Mise N, Tojo A, Miyashita K, Konno Y, Hirata Y, Goto A, Omata M. Relevance of periglomerular myofibroblasts in progression of human glomerulonephritis. Am J Kidney Dis 1998; 32: 419-425
41. Meyer TW, Anderson S, Rennke HG, Brenner BM. Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int 1987; 31: 752-759
42. Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985; 76: 612-619
43. Riser BL, Cortes P, Yee J. Modelling the effects of vascular stress in mesangial cells. Curr Opin Nephrol Hypertens 2000; 9: 43-47
44. Riser BL, Cortes P, Heilig C, Grondin J, Ladson-Wofford S, Patterson D, Narins RG. Cyclic stretching force selectively up-regulates transforming growth factor-beta isoforms in cultured rat mesangial cells. Am J Pathol 1996; 148: 1915-1923
45. Shimamura T, Morrison AB. A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats. Am J Pathol 1975; 79: 95-106
46. Fine LG, Orphanides C, Norman JT. Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int Suppl 1998; 65: S74-S78
47. Schrijvers BF, De Vriese AS, Flyvbjerg A. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev 2004; 25: 971-1010
48. Wang SN, La Page J, Hirschberg R. Glomerular ultrafiltration and apical tubular action of 1GF-1, TGF-beta, and HGF in nephrotic syndrome. Kidney Int 1999; 56: 1247-1251
49. Wang SN, LaPage J, Hirschberg R. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Kidney Int 2000; 57: 1002-1014
50. Creely JJ, DiMari SJ, Howe AM, Haralson MA. Effects of transforming growth factor-beta on collagen synthesis by normal rat kidney epithelial cells. Am J Pathol 1992; 140: 45-55
51. Daniel C, Wiede J, Krutzsch HC, Ribeiro SM, Roberts DD, Murphy-Ullrich JE, Hugo C. Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo. Kidney Int 2004; 65: 459-468
52. Ziyadeh FN, Sharma K, Ericksen M, Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 1994; 93: 536-542
53. Nakamura T, Miller D, Ruoslahti E, Border WA. Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1. Kidney Int 1992; 41: 1213-1221
54. Overall CM, Wrana JL, Sodek J. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem 1989; 264: 1860-1869
55. Hill C, Flyvbjerg A, Gronbaek H, Petrik J, Hill DJ, Thomas CR, Sheppard MC, Logan A. The renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats. Endocrinology 2000; 141: 1196-1208
56. Singh R, Song RH, Alavi N, Pegoraro AA, Singh AK, Leehey DJ. High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-betal. Exp Nephrol 2001; 9: 249-257
57. Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, Border WA. Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int 1996; 49: 461-469
58. Iwano M, Kubo A, Nishino T, Sato H, Nishioka H, Akai Y, Kurioka H, Fujii Y, Kanauchi M, Shiiki H, Dohi K. Quantification of glomerular TGF-b1 mRNA in patients with diabetes mellitus. Kidney Int 1996; 49: 1120-1126
59. Sharma K, Ziyadeh FN, Alzahab B, McGowan TA, Kapoor S, Kurnik BRC, Kurnik PB, Weisberg LS. Increased Renal Production of Transforming Growth Factor-b1 in Patients with Type II Diabetes. Diabetes 1997; 46: 854-859
60. Shankland SJ, Scholey JW, Ly H, Thai K. Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy. Kidney Int 1994; 46: 430-442
61. Sharma K, Ziyadeh FN. Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol 1994; 267: F1094-01
62. Olsen TS, Orskov H, Lundbaek K. Kidney lesions in rats with severe long-term alloxan diabetes. 2. Histochemical studies, comparison with human diabetic glomerular lesions. Acta Pathol Microbiol Scand 1966; 66: 1-12
63. Yang CW, Hattori M, Vlassara H, He CJ, Carome MA, Yamato E, Elliot S, Striker GE, Striker LJ. Overexpression of transforming growth factor-beta 1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice. J Am Soc Nephrol 1995; 5: 1610-1617
64. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A 1993; 90: 1814-1818
65. Bodi I, Kimmel PL, Abraham AA, Svetkey LP, Klotman PE, Kopp JB. Renal TGF-beta in HIV-associated kidney diseases. Kidney Int 1997; 51: 1568-1577
66. Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, Maki S. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 1993; 68: 154-163
67. Border WA, Yamamoto T, Noble NA. Transforming growth factor beta in diabetic nephropathy. Diabetes Metab Rev 1996; 12: 309-339
68. Niemir ZI, Stein H, Noronha IL, Krüger C, Andrassy K, Ritz E, Waldherr R. PDGF and TGF-beta contribute to the natural course of human IgA glomerulonephritis. Kidney Int 1995; 48: 1530-1541
69. Coimbra T, Wiggins R, Noh JW, Merritt S, Phan SH. Transforming growth factor-beta production in anti-glomerular basement membrane disease in the rabbit. Am J Pathol 1991; 138: 223-234
70. Yamamoto T, Noble NA, Miller DE, Border WA. Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int 1994; 45: 916-927
71. Border WA, Noble NA. TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int 1997; 51: 1388-1396
72. Border WA, Ruoslahti E. Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest 1992; 90: 1-7
73. Wogensen L, Nielsen CB, Hjorth P, Rasmussen LM, Høj Nielsen A, Gross K, Sarvetnick N, Ledet T. Under control of the Renin-1c promoter, Locally, produced transforming growth factor-b1 induces accumulation of glomerular extracellular matrix in transgenic mice. Diabetes 1999; 48: 182-192
74. Liu Y. Hepatocyte growth factor and the kidney. Curr Opin Nephrol Hypertens 2002; 11: 23-30
75. Mizuno S, Nakamura T. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy. Am J Physiol Renal Physiol 2004; 286: F134-F143
76. Cruzado JM, Lloberas N, Torras J, Riera M, Filiat C, Herrero-Fresneda I, Aran JM, Alperovich G, Vidal A, Grinyo JM. Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats. Diabetes 2004; 53: 1119-1127
77. Doi T, Striker LJ, Quaife C, Conti FG, Palmiter R, Behringer R, Brinster R, Striker GE. Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. Am J Pathol 1988; 131: 398-403
78. Doi T, Striker LJ, Gibson CC, Agodoa LY, Brinster RL, Striker GE. Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. Am J Pathol 1990; 137: 541-552
79. Doi T, Striker LJ, Kimata K, Peten EP, Yamada Y, Striker GE. Glomerulosclerosis in mice transgenic for growth hormone. Increased mesangial extracellular matrix is correlated with kidney mRNA levels. J Exp Med 1991; 173: 1287-1290
80. Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, Klotman PE, Thorgeirsson SS. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 1996; 74: 991-1003
81. Clouthier DE, Comerford SA, Hammer RE. Hepatic Fibrosis, Glomerulosclerosis, and a Lipodystrophy-like Syndrome in PEPCK-TGF-b1 Transgenic mice. J Clin Invest 1997; 100: 2697-2713
82. Kopp JB. Glomerulosclerosis, tubulointerstitial fibrosis, and obstructive uropathy in PEPCK-TGF-betal transgenic mice. Am J Kidney Dis 1999; 34: 177-183
83. Krag S, Østerby R, Chai Q, Nielsen B, Hermans C, Wogensen L. TGF-b1-induced glomerular disorder is associated with impaired concentrating ability mimicking primary glomerular disease with renal failure in man. Lab Invest 2000; 80: 1855-1868
84. Østerby R. Lesions from kidney biopsies. Diabetes Metab Rev 1996; 12: 151-174
85. Chai Q, Krag S, Miner JH, Nyengaard JR, Chai S, Wogensen L. TGF-beta1 induces aberrant laminin chain and collagen type IV isotype expression in the glomerular basement membrane. Nephron Exp Nephrol 2003; 94: e123-e136
86. Birch NC, Krag S, Osterby R, Flyvbjerg A, Nyengaard J, Forman A, Wogensen L. Transforming growth factor beta 1-induced glomerulopathy is prevented by 17beta-estradiol supplementation. Virchows Arch 2004; 444: 561-566
87. Chai Q, Krag S, Chai S, Ledet T, Wogensen L. Localisation and phenotypical characterisation of collagen-producing cells in TGF-beta 1-induced renal interstitial fibrosis. Histochem Cell Biol 2003; 119: 267-280
88. Cosgrove D, Rodgers KD, Meehan DT, Miller CC, Bovard K, Gilroy A, Gardner H, Koteliansky V, Gotwals P, Amatucci A, Kalluri R. Integrin alb1 and Transforming growth factor-b1 play distinct roles in Alport glomerular pathogenesis and serve dual targets for metabolic therapy. Am J Pathol 2000; 157: 1649-1659
89. Kashtan CE, Kim Y, Lees GE,Thorner PS, Virtanen I, MinerJH. Abnormal glomerular basement membrane laminins in murine, canine, and human Alport syndrome: aberrant laminin alpha2 deposition is species independent. J Am Soc Nephrol 2001; 12: 252-260
90. Takeuchi A, Yoshizawa N, Yamamoto M, Sawasaki Y, Oda T, Senoo A, Niwa H, Fuse Y. Basic fibroblast growth factor promotes proliferation of rat glomerular visceral epithelial cells in vitro. Am J Pathol 1992; 141: 107-116
91. van Det NF, Verhagen NAM, Tamsma JT, Berden JHM, Bruijn JA, Daha MR, van der Woude FJ. Regulation of Glomerular Epithelial Cell Production of Fibronectin and Transforming Growth Factor-b by High Glucose, Not by Angiotensin II. Diabetes 1997; 46: 834-840
92. Neubauer K, Kruger M, Quondamatteo F, Knittel T, Saile B, Ramadori G. Transforming growth factor-betal stimulates the synthesis of basement membrane proteins laminin, collagen type IV and entactin in rat liver sinusoidal endothelial cells. J Hepatol 1999; 31: 692-702
93. MacKay K, Striker LJ, Stauffer JW, Doi T, Agodoa LY, Striker GE. Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 1989; 83: 1160-1167
94. Bertelli R, Valenti F, Oleggini R, Caridi G, Altieri P, Coviello DA, Botti G, Ravazzolo R, Ghiggeri GM. Cell-specific regulation of alpha 1 (III) and alpha2(V) collagen by TGF-betal in tubulointerstitial cell models. Nephrol Dial Transplant 1998; 13: 573-579
95. Han DC, Isono M, Huffman BB, Ziyadeh FN. High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: mediation by autocrine activation of TGF-beta. J Am Soc Nephrol 1999; 10: 1891-1899
96. Le Meur Y, Tesch GH, Rice E, Foti R, Atkins RC, Paterson DJN. Blockade of macrophage accumulation has no effect on renal fibrosis in obstructive nephropathy. Ref Type: Abstract. J Am Soc Nephrol 2001; 12: 708A
97. Shankland SJ, Johnson RJ. TGF-beta in glomerular disease. Miner Electrolyte Metab 1998; 24: 168-173